For instance, it has been shown that leukemic cells (CD20+) and myeloid cells (CD68+) express hCAP18/LL-37 in patients with chronic lymphocytic leukemia, suggesting that signals from the microenvironment promote its expression [34]. The gene discussed is CAMP; the disease is B-cell chronic lymphocytic leukemia.